Questionnaire of the Section Perioperative Intensive Care of the European Society of Intensive Care Medicine (ESICM) on Standardized Drug Labelling

N/ACompletedNCT01232088

Charite University, Berlin, Germany482 enrolled

Overview

Medication errors are common in intensive care (Valentin A et al., BMJ. 2009;338). Standardized color coded labels for user applied syringes enjoy strong support from many health professionals, thinking that this might increase patient safety. Whether this is true or not warrants further research.

Study Type

OBSERVATIONAL

Enrollment

482

Conditions

Drug Labelling

Eligibility

Sex: ALLMin age: 18 YearsMax age: 100 Years

Medical Language ↔ Plain English

Inclusion Criteria: Members of the European Society of Intensive Care Medicine (ESICM)

Locations (1)

Department of Anesthesiology and Intensive Care Medicine Campus Virchow Klinikum/Campus Charité Mitte

Berlin, State of Berlin, Germany

Outcomes

Primary Outcomes

The primary objective is to assess if standardized drug syringe labelling is used in European ICUs.

Online survey for ICU physicians (members of the ESICM).

Time frame: A period of 90 days.

Secondary Outcomes

The second objectives is to assess 1. if standards for drug syringe labelling are similar in European ICUs and 2. if users expect that standardized drug syringe labelling should be delivered by the pharmaceutical industry.

Online survey for ICU physicians (members of the ESICM).

Time frame: A period of 90 days

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.